CLINICAL_TRIALS
research
· 2026-01-22
Clinical Trial Update: Subthalamic Nucleus (STN) Targeted Transcranial Temporal Interference Stimulation (TIS) Treats Parkinson's Disease [NA]
Summary
A clinical trial is investigating subthalamic nucleus targeted transcranial temporal interference stimulation as a treatment for Parkinson's disease; the study …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Tang Zhouping | Conditions: Parkinson Disease | NA | Status: NOT_YET_RECRUITING